Abstract

HE COST-EFFECTIVENESS OF IN-][21] To date, only 1 randomized, placebocontrolled cost-effectiveness study among healthy working adults has been published. 6That study, conducted from the societal perspective, reported a net savings of $46.85 per healthy adult worker vaccinated against influenza.3][14][15][16][17][18] Most influenza vaccine studies of healthy working adults have been